
The automated nucleic acid isolation platform is a device used to extract nucleic acids (such as DNA, RNA) from biological samples efficiently, accurately and reproducibly. These platforms are commonly used in areas such as molecular biology research, clinical diagnostics, and biological sample processing.
The global Automated Nucleic Acid Isolation Platform market was valued at US$ 565 million in 2023 and is anticipated to reach US$ 797.4 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Automated Nucleic Acid Isolation Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Nucleic Acid Isolation Platform.
Report Scope
The Automated Nucleic Acid Isolation Platform market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Nucleic Acid Isolation Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Nucleic Acid Isolation Platform manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Thermo Fisher Scientific
Merck KGaA
Roche
Danaher
PerkinElmer
Agilent
Promega
Bio-Rad
Takara Bio
Kurabo Biomedical
LGC Biosearch
Abcam
Bioneer
Meridian Bioscience
CW Bio
Apostle
Esco Lifesciences
Aurora Biomed
Segment by Type
DNA Isolation
RNA Isolation
Segment by Application
Outpatient Lab
Hospital
Testing Agency
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Nucleic Acid Isolation Platform manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Nucleic Acid Isolation Platform in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Automated Nucleic Acid Isolation Platform Market Overview
1.1 Product Overview and Scope of Automated Nucleic Acid Isolation Platform
1.2 Automated Nucleic Acid Isolation Platform Segment by Type
1.2.1 Global Automated Nucleic Acid Isolation Platform Market Value Comparison by Type (2024-2030)
1.2.2 DNA Isolation
1.2.3 RNA Isolation
1.3 Automated Nucleic Acid Isolation Platform Segment by Application
1.3.1 Global Automated Nucleic Acid Isolation Platform Market Value by Application: (2024-2030)
1.3.2 Outpatient Lab
1.3.3 Hospital
1.3.4 Testing Agency
1.3.5 Other
1.4 Global Automated Nucleic Acid Isolation Platform Market Size Estimates and Forecasts
1.4.1 Global Automated Nucleic Acid Isolation Platform Revenue 2019-2030
1.4.2 Global Automated Nucleic Acid Isolation Platform Sales 2019-2030
1.4.3 Global Automated Nucleic Acid Isolation Platform Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automated Nucleic Acid Isolation Platform Market Competition by Manufacturers
2.1 Global Automated Nucleic Acid Isolation Platform Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automated Nucleic Acid Isolation Platform Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automated Nucleic Acid Isolation Platform Average Price by Manufacturers (2019-2024)
2.4 Global Automated Nucleic Acid Isolation Platform Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automated Nucleic Acid Isolation Platform, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Nucleic Acid Isolation Platform, Product Type & Application
2.7 Automated Nucleic Acid Isolation Platform Market Competitive Situation and Trends
2.7.1 Automated Nucleic Acid Isolation Platform Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Nucleic Acid Isolation Platform Players Market Share by Revenue
2.7.3 Global Automated Nucleic Acid Isolation Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Nucleic Acid Isolation Platform Retrospective Market Scenario by Region
3.1 Global Automated Nucleic Acid Isolation Platform Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automated Nucleic Acid Isolation Platform Global Automated Nucleic Acid Isolation Platform Sales by Region: 2019-2030
3.2.1 Global Automated Nucleic Acid Isolation Platform Sales by Region: 2019-2024
3.2.2 Global Automated Nucleic Acid Isolation Platform Sales by Region: 2025-2030
3.3 Global Automated Nucleic Acid Isolation Platform Global Automated Nucleic Acid Isolation Platform Revenue by Region: 2019-2030
3.3.1 Global Automated Nucleic Acid Isolation Platform Revenue by Region: 2019-2024
3.3.2 Global Automated Nucleic Acid Isolation Platform Revenue by Region: 2025-2030
3.4 North America Automated Nucleic Acid Isolation Platform Market Facts & Figures by Country
3.4.1 North America Automated Nucleic Acid Isolation Platform Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automated Nucleic Acid Isolation Platform Sales by Country (2019-2030)
3.4.3 North America Automated Nucleic Acid Isolation Platform Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automated Nucleic Acid Isolation Platform Market Facts & Figures by Country
3.5.1 Europe Automated Nucleic Acid Isolation Platform Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automated Nucleic Acid Isolation Platform Sales by Country (2019-2030)
3.5.3 Europe Automated Nucleic Acid Isolation Platform Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Nucleic Acid Isolation Platform Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Nucleic Acid Isolation Platform Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automated Nucleic Acid Isolation Platform Sales by Country (2019-2030)
3.6.3 Asia Pacific Automated Nucleic Acid Isolation Platform Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Automated Nucleic Acid Isolation Platform Market Facts & Figures by Country
3.7.1 Latin America Automated Nucleic Acid Isolation Platform Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automated Nucleic Acid Isolation Platform Sales by Country (2019-2030)
3.7.3 Latin America Automated Nucleic Acid Isolation Platform Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Nucleic Acid Isolation Platform Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Nucleic Acid Isolation Platform Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automated Nucleic Acid Isolation Platform Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automated Nucleic Acid Isolation Platform Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Nucleic Acid Isolation Platform Sales by Type (2019-2030)
4.1.1 Global Automated Nucleic Acid Isolation Platform Sales by Type (2019-2024)
4.1.2 Global Automated Nucleic Acid Isolation Platform Sales by Type (2025-2030)
4.1.3 Global Automated Nucleic Acid Isolation Platform Sales Market Share by Type (2019-2030)
4.2 Global Automated Nucleic Acid Isolation Platform Revenue by Type (2019-2030)
4.2.1 Global Automated Nucleic Acid Isolation Platform Revenue by Type (2019-2024)
4.2.2 Global Automated Nucleic Acid Isolation Platform Revenue by Type (2025-2030)
4.2.3 Global Automated Nucleic Acid Isolation Platform Revenue Market Share by Type (2019-2030)
4.3 Global Automated Nucleic Acid Isolation Platform Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automated Nucleic Acid Isolation Platform Sales by Application (2019-2030)
5.1.1 Global Automated Nucleic Acid Isolation Platform Sales by Application (2019-2024)
5.1.2 Global Automated Nucleic Acid Isolation Platform Sales by Application (2025-2030)
5.1.3 Global Automated Nucleic Acid Isolation Platform Sales Market Share by Application (2019-2030)
5.2 Global Automated Nucleic Acid Isolation Platform Revenue by Application (2019-2030)
5.2.1 Global Automated Nucleic Acid Isolation Platform Revenue by Application (2019-2024)
5.2.2 Global Automated Nucleic Acid Isolation Platform Revenue by Application (2025-2030)
5.2.3 Global Automated Nucleic Acid Isolation Platform Revenue Market Share by Application (2019-2030)
5.3 Global Automated Nucleic Acid Isolation Platform Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Qiagen
6.1.1 Qiagen Corporation Information
6.1.2 Qiagen Description and Business Overview
6.1.3 Qiagen Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Qiagen Automated Nucleic Acid Isolation Platform Product Portfolio
6.1.5 Qiagen Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific Automated Nucleic Acid Isolation Platform Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Merck KGaA
6.3.1 Merck KGaA Corporation Information
6.3.2 Merck KGaA Description and Business Overview
6.3.3 Merck KGaA Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck KGaA Automated Nucleic Acid Isolation Platform Product Portfolio
6.3.5 Merck KGaA Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Automated Nucleic Acid Isolation Platform Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Corporation Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Danaher Automated Nucleic Acid Isolation Platform Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 PerkinElmer
6.6.1 PerkinElmer Corporation Information
6.6.2 PerkinElmer Description and Business Overview
6.6.3 PerkinElmer Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.6.4 PerkinElmer Automated Nucleic Acid Isolation Platform Product Portfolio
6.6.5 PerkinElmer Recent Developments/Updates
6.7 Agilent
6.6.1 Agilent Corporation Information
6.6.2 Agilent Description and Business Overview
6.6.3 Agilent Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Agilent Automated Nucleic Acid Isolation Platform Product Portfolio
6.7.5 Agilent Recent Developments/Updates
6.8 Promega
6.8.1 Promega Corporation Information
6.8.2 Promega Description and Business Overview
6.8.3 Promega Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Promega Automated Nucleic Acid Isolation Platform Product Portfolio
6.8.5 Promega Recent Developments/Updates
6.9 Bio-Rad
6.9.1 Bio-Rad Corporation Information
6.9.2 Bio-Rad Description and Business Overview
6.9.3 Bio-Rad Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bio-Rad Automated Nucleic Acid Isolation Platform Product Portfolio
6.9.5 Bio-Rad Recent Developments/Updates
6.10 Takara Bio
6.10.1 Takara Bio Corporation Information
6.10.2 Takara Bio Description and Business Overview
6.10.3 Takara Bio Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Takara Bio Automated Nucleic Acid Isolation Platform Product Portfolio
6.10.5 Takara Bio Recent Developments/Updates
6.11 Kurabo Biomedical
6.11.1 Kurabo Biomedical Corporation Information
6.11.2 Kurabo Biomedical Automated Nucleic Acid Isolation Platform Description and Business Overview
6.11.3 Kurabo Biomedical Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kurabo Biomedical Automated Nucleic Acid Isolation Platform Product Portfolio
6.11.5 Kurabo Biomedical Recent Developments/Updates
6.12 LGC Biosearch
6.12.1 LGC Biosearch Corporation Information
6.12.2 LGC Biosearch Automated Nucleic Acid Isolation Platform Description and Business Overview
6.12.3 LGC Biosearch Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.12.4 LGC Biosearch Automated Nucleic Acid Isolation Platform Product Portfolio
6.12.5 LGC Biosearch Recent Developments/Updates
6.13 Abcam
6.13.1 Abcam Corporation Information
6.13.2 Abcam Automated Nucleic Acid Isolation Platform Description and Business Overview
6.13.3 Abcam Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Abcam Automated Nucleic Acid Isolation Platform Product Portfolio
6.13.5 Abcam Recent Developments/Updates
6.14 Bioneer
6.14.1 Bioneer Corporation Information
6.14.2 Bioneer Automated Nucleic Acid Isolation Platform Description and Business Overview
6.14.3 Bioneer Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bioneer Automated Nucleic Acid Isolation Platform Product Portfolio
6.14.5 Bioneer Recent Developments/Updates
6.15 Meridian Bioscience
6.15.1 Meridian Bioscience Corporation Information
6.15.2 Meridian Bioscience Automated Nucleic Acid Isolation Platform Description and Business Overview
6.15.3 Meridian Bioscience Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Meridian Bioscience Automated Nucleic Acid Isolation Platform Product Portfolio
6.15.5 Meridian Bioscience Recent Developments/Updates
6.16 CW Bio
6.16.1 CW Bio Corporation Information
6.16.2 CW Bio Automated Nucleic Acid Isolation Platform Description and Business Overview
6.16.3 CW Bio Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CW Bio Automated Nucleic Acid Isolation Platform Product Portfolio
6.16.5 CW Bio Recent Developments/Updates
6.17 Apostle
6.17.1 Apostle Corporation Information
6.17.2 Apostle Automated Nucleic Acid Isolation Platform Description and Business Overview
6.17.3 Apostle Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Apostle Automated Nucleic Acid Isolation Platform Product Portfolio
6.17.5 Apostle Recent Developments/Updates
6.18 Esco Lifesciences
6.18.1 Esco Lifesciences Corporation Information
6.18.2 Esco Lifesciences Automated Nucleic Acid Isolation Platform Description and Business Overview
6.18.3 Esco Lifesciences Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Esco Lifesciences Automated Nucleic Acid Isolation Platform Product Portfolio
6.18.5 Esco Lifesciences Recent Developments/Updates
6.19 Aurora Biomed
6.19.1 Aurora Biomed Corporation Information
6.19.2 Aurora Biomed Automated Nucleic Acid Isolation Platform Description and Business Overview
6.19.3 Aurora Biomed Automated Nucleic Acid Isolation Platform Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Aurora Biomed Automated Nucleic Acid Isolation Platform Product Portfolio
6.19.5 Aurora Biomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Nucleic Acid Isolation Platform Industry Chain Analysis
7.2 Automated Nucleic Acid Isolation Platform Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Nucleic Acid Isolation Platform Production Mode & Process
7.4 Automated Nucleic Acid Isolation Platform Sales and Marketing
7.4.1 Automated Nucleic Acid Isolation Platform Sales Channels
7.4.2 Automated Nucleic Acid Isolation Platform Distributors
7.5 Automated Nucleic Acid Isolation Platform Customers
8 Automated Nucleic Acid Isolation Platform Market Dynamics
8.1 Automated Nucleic Acid Isolation Platform Industry Trends
8.2 Automated Nucleic Acid Isolation Platform Market Drivers
8.3 Automated Nucleic Acid Isolation Platform Market Challenges
8.4 Automated Nucleic Acid Isolation Platform Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Qiagen
Thermo Fisher Scientific
Merck KGaA
Roche
Danaher
PerkinElmer
Agilent
Promega
Bio-Rad
Takara Bio
Kurabo Biomedical
LGC Biosearch
Abcam
Bioneer
Meridian Bioscience
CW Bio
Apostle
Esco Lifesciences
Aurora Biomed
Ìý
Ìý
*If Applicable.
